Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Hepatic manifestations and impact of COVID-19 on the cirrhotic patient
J.A. Velarde-Ruiz Velasco; E.S. García-Jiménez; J.M. Remes-Troche;
Rev Gastroenterol Mex. 2020;85:303-11
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024
J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;
10.1016/j.rgmxen.2024.10.009
Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms
F. Higuera-de-la-Tijera; A. Servín-Caamaño; F. Lajud-Barquín; A. Tovar-Aguilar;
Rev Gastroenterol Mex. 2024;89:481-90